Benito Pataroque, MD
Internal Medicine · Tualatin, ORNPI 1033100714
Payments from drug & device makers
Across 676 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- Johnson & Johnson$2K
- AstraZeneca$2K
- AbbVie$1K
- Amgen$1K
- Novo Nordisk$1K
- plus $6K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 113 | $2,107 |
| Johnson & Johnson | 63 | $1,610 |
| AstraZeneca | 67 | $1,595 |
| AbbVie(2 entities) | 77 | $1,177 |
| Amgen(2 entities) | 45 | $1,130 |
| Novo Nordisk | 47 | $1,058 |
| Lilly USA, LLC | 47 | $1,014 |
| E.r. Squibb & Sons, L.L.C. | 27 | $626 |
| Bayer | 23 | $551 |
| Edwards Lifesciences | 12 | $515 |
| Boehringer Ingelheim | 22 | $484 |
| Amarin Pharma, Inc. | 26 | $387 |
| Otsuka America Pharmaceutical, Inc. | 15 | $371 |
| Sanofi-aventis U.S. LLC | 21 | $364 |
| Exact Sciences | 9 | $253 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $243 |
| Novartis | 8 | $197 |
| Merck | 10 | $190 |
| Phathom Pharmaceuticals, Inc. | 5 | $154 |
| Biohaven Pharmaceuticals, Inc. | 5 | $98 |
| Boston Scientific | 4 | $83 |
| Lundbeck LLC | 3 | $80 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $76 |
| Abbott | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Medtronic(2 entities) | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $39 |
| Amphastar Pharmaceuticals, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| GSK | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
How this compares
$14,765 in reported general payments places this provider in the 95th percentile of 1,363 internal medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Tualatin
- John Thomas ForsytheTualatin$142K
- Hidenao KimuraTualatin$11K
- Corona FreitagTualatin$4K
- Stephen SpurgeonPortland$8.6M
- Drissana TranSalem$4.8M
- James BergtholdPortland$4.7M
- Stephen FortmannPortland$3.3M
- Maryann ConradPortland$2.7M
- Brian CurtisCorvallis$2.4M
- Jennifer SaultzPortland$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.